The Nobel Prize in medicine was awarded to Victor Ambros, PhD, of the University of Massachusetts, and Gary Ruvkun, PhD, of ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
The venture capital firm Atlas Venture is launching a start-up that aims to develop antisense oligonucleotides for a ...
An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.
This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.
Penn Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary ...
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...
RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...